Patents by Inventor Michael P. Rettig

Michael P. Rettig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for treatment of cancer
    Patent number: 11696926
    Abstract: Among the various aspects of the present disclosure is the provision of methods and compositions for upregulating MHC class II in cancer cells (e.g., a hematological cancer cell). Also provided are methods of treatment for subjects suffering from hematological cancers, comprising administration of interferon-? (IFN-?). The methods of treatment provided herein may be particularly suitable for subjects who have received an allogenic transplant or have suffered a relapse.
    Type: Grant
    Filed: January 28, 2020
    Date of Patent: July 11, 2023
    Assignee: Washington University
    Inventors: Matthew Christopher, John F. DiPersio, Timothy J. Ley, Allegra Petti, Michael P. Rettig
  • METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER
    Publication number: 20200237817
    Abstract: Among the various aspects of the present disclosure is the provision of methods and compositions for upregulating MHC class II in cancer cells (e.g., a hematological cancer cell). Also provided are methods of treatment for subjects suffering from hematological cancers, comprising administration of interferon-? (IFN-?). The methods of treatment provided herein may be particularly suitable for subjects who have received an allogenic transplant or have suffered a relapse.
    Type: Application
    Filed: January 28, 2020
    Publication date: July 30, 2020
    Applicant: Washington University
    Inventors: Matthew Christopher, John F. DiPersio, Timothy J. Ley, Allegra Petti, Michael P. Rettig